| 1 |
31105786 | Inhibitory effect of simvastatin in nasopharyngeal carcinoma cells. | 2019 Jun |
1 |
| 2 |
31452046 | Anti-leukemic effects of simvastatin on NRASG12D mutant acute myeloid leukemia cells. | 2019 Dec |
1 |
| 3 |
28916945 | Simvastatin enhances radiation sensitivity of colorectal cancer cells. | 2018 Mar |
1 |
| 4 |
29795329 | Integration of Ca2+ signaling regulates the breast tumor cell response to simvastatin and doxorubicin. | 2018 Sep |
1 |
| 5 |
29916838 | Simvastatin reverses multiple myeloma serum-induced prothrombotic phenotype in endothelial cells via ERK 1/2 signalling pathway. | 2018 Sep |
2 |
| 6 |
30513525 | Simvastatin Protects Dopaminergic Neurons Against MPP+-Induced Oxidative Stress and Regulates the Endogenous Anti-Oxidant System Through ERK. | 2018 |
5 |
| 7 |
30584296 | The role of the ERK1/2 pathway in simvastatin-loaded nanomicelles and simvastatin in regulating the osteogenic effect in MG63 cells. | 2018 |
4 |
| 8 |
28968609 | Inhibition of Prenylation Promotes Caspase 3 Activation, Lamin B Degradation and Loss in Metabolic Cell Viability in Pancreatic β-Cells. | 2017 |
1 |
| 9 |
26565813 | Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway. | 2016 Jan 19 |
2 |
| 10 |
26756263 | The apoptotic effect of simvastatin via the upregulation of BIM in nonsmall cell lung cancer cells. | 2016 |
2 |
| 11 |
26875818 | Simvastatin and atorvastatin facilitates amyloid β-protein degradation in extracellular spaces by increasing neprilysin secretion from astrocytes through activation of MAPK/Erk1/2 pathways. | 2016 Jun |
2 |
| 12 |
27123120 | Simvastatin blocks TGF-β1-induced epithelial-mesenchymal transition in human prostate cancer cells. | 2016 May |
1 |
| 13 |
27347133 | Statin induces apoptosis of human colon cancer cells and downregulation of insulin-like growth factor 1 receptor via proapoptotic ERK activation. | 2016 Jul |
1 |
| 14 |
25432084 | Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide. | 2014 Nov 29 |
2 |
| 15 |
23352311 | Reduction of platelet cytosolic phospholipase A2 activity by atorvastatin and simvastatin: biochemical regulatory mechanisms. | 2013 Apr |
1 |
| 16 |
23558220 | Decreased tissue levels of cyclophilin A, a cyclosporine a target and phospho-ERK1/2 in simvastatin patients with abdominal aortic aneurysm. | 2013 Jun |
3 |
| 17 |
24080182 | Simvastatin increases Prolyl-4-Hydroxylase α1 expression in atherosclerotic plaque and ox-LDL-stimulated human aortic smooth muscle cells via p38 MAPK and ERK1/2 signaling. | 2013 Dec |
4 |
| 18 |
21052011 | Simvastatin reduces lipoprotein-associated phospholipase A2 in lipopolysaccharide-stimulated human monocyte-derived macrophages through inhibition of the mevalonate-geranylgeranyl pyrophosphate-RhoA-p38 mitogen-activated protein kinase pathway. | 2011 Feb |
1 |
| 19 |
20614159 | Simvastatin overcomes the resistance to serum withdrawal-induced apoptosis of lymphocytes from Alzheimer's disease patients. | 2010 Dec |
1 |
| 20 |
20671065 | High-density lipoprotein induces proliferation and migration of human prostate androgen-independent cancer cells by an ABCA1-dependent mechanism. | 2010 Sep |
1 |
| 21 |
17464346 | The inhibitory effect of simvastatin on the ADMA-induced inflammatory reaction is mediated by MAPK pathways in endothelial cells. | 2007 Feb |
2 |
| 22 |
15069546 | Effects of an HMG-CoA reductase inhibitor, simvastatin, on human myeloma cells. | 2004 May |
1 |